Callan Capital’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-176,777
Closed -$162K 70
2016
Q2
$162K Hold
176,777
0.07% 61
2016
Q1
$249K Buy
176,777
+300
+0.2% +$447 0.1% 53
2015
Q4
$289K Hold
176,477
0.11% 50
2015
Q3
$309K Sell
176,477
-100,000
-36% -$245K 0.17% 49
2015
Q2
$840K Buy
276,477
+10,000
+4% +$37.6K 0.18% 46
2015
Q1
$1.05M Hold
266,477
0.22% 41
2014
Q4
$986K Hold
266,477
0.22% 45
2014
Q3
$791K Hold
266,477
0.22% 41
2014
Q2
$1.03M Buy
266,477
+176,477
+196% +$516K 0.28% 40
2014
Q1
$221K Hold
90,000
0.07% 47
2013
Q4
$211K Buy
90,000
+50,000
+125% +$119K 0.08% 43
2013
Q3
$107K Buy
+40,000
New +$134K 0.05% 40

Callan Capital's SQNM Position: Q3 2016 in Review

Callan Capital sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 176,777 shares — an estimated $162K sold.

Callan Capital first reported a position in SQNM in Q3 2013 and held it in 12 quarters. The position peaked at $1.05M in Q1 2015. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.

  • Callan Capital reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
  • Callan Capital sold 176,777 SEQUENOM INC NEW shares in Q3 2016, an estimated $162K.
  • Callan Capital first reported a position in SEQUENOM INC NEW in Q3 2013 and held it in 12 quarters.
  • Callan Capital's SEQUENOM INC NEW position peaked at $1.05M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.

Based on Callan Capital's 13F filing for Q3 2016, filed 15 Nov 2016.